Belsomra

Insomnia
Treatment
1 FDA approval
1 Active Study for Belsomra

What is Belsomra

SuvorexantThe Generic name of this drug
Treatment SummarySuvorexant is a medication used to treat insomnia by reducing your wakefulness and making it easier to fall asleep. It works by blocking the activity of two receptors called OX1R and OX2R, which are involved in controlling your sleep-wake cycle.
Belsomrais the brand name
image of different drug pills on a surface
Belsomra Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Belsomra
Suvorexant
2014
4

Approved as Treatment by the FDA

Suvorexant, also known as Belsomra, is approved by the FDA for 1 uses including Insomnia .
Insomnia

Effectiveness

How Belsomra works in the bodySuvorexant works by blocking two special receptors in the brain that are associated with wakefulness. These receptors are called OX1R and OX2R. When suvorexant blocks them, it prevents the reinforcement of the arousal systems, which reduces arousal and wakefulness, helping you to fall asleep.

When to interrupt dosage

The measure of Belsomra is contingent upon the determined condition. The amount also differs as per the technique of delivery outlined in the table beneath.
Condition
Dosage
Administration
Insomnia
, 5.0 mg, 10.0 mg, 15.0 mg, 20.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet

Warnings

There are 20 known major drug interactions with Belsomra.
Common Belsomra Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be increased when it is combined with Suvorexant.
Axitinib
Major
The serum concentration of Axitinib can be increased when it is combined with Suvorexant.
Azelastine
Major
Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Bendamustine
Major
The serum concentration of Bendamustine can be increased when it is combined with Suvorexant.
Binimetinib
Major
The serum concentration of Binimetinib can be increased when it is combined with Suvorexant.
Belsomra Toxicity & Overdose RiskCommon side effects of suvorexant include feeling drowsy and having a decreased level of alertness. It is not recommended to use suvorexant if you need to drive, as it can impair your driving skills. Taking a higher dose or using it with less than a full night of sleep remaining can increase the chance of feeling drowsy the next day. Suvorexant has been linked to sleepwalking, sleep driving, and other complex behaviours, as well as suicidal ideation, sleep paralysis, vivid dreaming, and mild cataplexy. It is not known if suvorexant is
image of a doctor in a lab doing drug, clinical research

Belsomra Novel Uses: Which Conditions Have a Clinical Trial Featuring Belsomra?

82 ongoing investigations are examining the potential of Belsomra to alleviate Insomnia symptoms.
Condition
Clinical Trials
Trial Phases
Insomnia
1 Actively Recruiting
Not Applicable

Belsomra Reviews: What are patients saying about Belsomra?

3.3Patient Review
1/25/2022
Belsomra for Chronic Trouble Sleeping
This sleeping medication was pretty terrible and not effective for me. I would suggest avoiding it.
2.3Patient Review
4/24/2022
Belsomra for Chronic Trouble Sleeping
Belsomra did not help me to get to sleep. Once I was asleep my quality of sleep was better. But anytime I had to get up during the night it was hard to get back to sleep.
2.3Patient Review
1/20/2022
Belsomra for Chronic Trouble Sleeping
This caused me to act out physically and verbally. I need help if anyone has any suggestions.
2Patient Review
9/9/2022
Belsomra for Chronic Trouble Sleeping
I had some seriously strange dreams while on this medication. Be very careful getting out of bed after taking it, as you may not be entirely coherent. I discontinued use because the nightmares were becoming too much.
2Patient Review
8/12/2022
Belsomra for Chronic Trouble Sleeping
This was a complete waste of money. It did nothing to help me whatsoever.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about belsomra

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Belsomra considered a narcotic?

"Belsomra is not a narcotic. It is a drug used to treat insomnia and belongs to a class of drugs called dual orexin receptor antagonists (DORAs)."

Answered by AI

What is Belsomra used to treat?

"BELSOMRA is a medicine that is taken by adults who have trouble falling or staying asleep. It is not known if it is effective in children under the age of 18 years."

Answered by AI

Is Belsomra a narcotic?

"Belsomra is not a narcotic drug, it is used to treat insomnia instead. It belongs to a class of drugs called dual orexin receptor antagonists (DORAs), which are not narcotics."

Answered by AI

Is Belsomra similar to Ambien?

"The medications Ambien and Belsomra are both used as sedatives and hypnotics to help with insomnia. They can cause similar side effects like making you feel drowsy during the day, dizzy, having a dry mouth, diarrhea, and getting headaches."

Answered by AI

What is Belsomra prescribed for?

"It is not known if BELSOMRA is safe and effective in children under the age of 18 years."

Answered by AI

Is Belsomra the same as Ambien?

"Belsomra works by blocking the action of a substance in the brain that causes wakefulness. This allows the patient to sleep. Ambien (zolpidem) is classified in a group of medicines called sedative-hypnotics. Ambien works by slowing down activity in the brain to help the patient sleep."

Answered by AI

Is Belsomra a good sleeping pill?

"Compared to those who took a placebo, patients who took BELSOMRA fell asleep faster and stayed asleep for a longer amount of time."

Answered by AI

Clinical Trials for Belsomra

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top